News

2008 Mid-Atlantic Bio to be Held October 22-24, 2008

CHANTILLY, Va.-(Business Wire)-October 1, 2008 - Mid-Atlantic Bio:


WHO:

	Keynote Speakers Include:

	Kary Mullis, Ph.D., Nobel Laureate

	The Honorable Timothy M. Kaine, Governor, Commonwealth of Virginia

	Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration

	David M. Mott, General Partner, New Enterprise Associates; Former President and CEO, MedImmune

	The Honorable Billy Tauzin, President and CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)

	Jeremy Levin, D.Phil., Senior Vice President of External Science, Technology and Licensing, Bristol-Myers Squibb

WHEN:

	Mid-Atlantic Bio runs from Wednesday, October 22, through Friday, October 24, 2008.

	See complete agenda at www.MidAtlanticBio.org.

WHERE:

	Westfields Marriott Washington Dulles, 14750 Conference Center Drive, Chantilly, Virginia

TO REGISTER:

	Media registration is open to editors and reporters working full time for print, broadcast or Web publications with valid press credentials. All media are strongly encouraged to register in advance. To request media registration, please e-mail Monica Welch or call (301) 933-1976.

About 2008 Mid-Atlantic Bio

Mid-Atlantic Bio is the only regional event to combine components of an industry convention and investor conference under one roof. Co-hosted by the Tech Council of Maryland/MdBio (TCM/MdBio), the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO), the initiative benefits from broad regional support, including the investor and greater business communities, academic institutions, government agencies, and partnered regional associations. The event aims to bring together a critical mass of public and private stakeholders, including biotechnology and pharmaceutical senior executives, scientists and researchers, academia, policy makers, legislators, and venture capitalists to provide a premiere mid-Atlantic networking and business development forum, leverage the region's world-renowned R&D resources and opportunities, and favorably position the region's biotechnology industry in terms of its collective strengths, resources and competencies among key constituencies.

About the Tech Council of Maryland/MdBio

The MdBio Division of Tech Council of Maryland seeks to support and advance the bioscience industry in Maryland and the region. The mission of the 150-member MdBio division is to create an environment where bioscience businesses can collaborate, grow and succeed. For more information, please visit www.techcouncilmd.com.

About Mid-Atlantic Venture Association

Founded in 1986, MAVA represents the collective interests of venture capitalists investing in the mid-Atlantic, including more than 500+ venture professionals, at 125 firms, with more than $90 billion in capital under management. For more information, please visit www.mava.org.

About Virginia Biotechnology Association

Virginia Biotechnology Association (VaBIO) is the 150-member statewide trade group that promotes the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. For more information, please visit www.vabio.org.

Send this news item to a friend.

Print This Page